In addition, high expression of FTO in ccRCC cells with a low expression of HIF2α contributes to the progression of ccRCC through stabilizing bromodomain-containing protein 9 mRNA by acting as m6A demethylase [116]. The gene discussed is FTO; the disease is nonpapillary renal cell carcinoma.